fbpx

Optometry Giving Sight Announces 2024 Grant Winners

Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight (OGS) has announced the selection of its 2024 grant program recipients. This year, 16 grants totaling almost $1 million USD have been awarded to 15 organizations for projects that will help eradicate uncorrected refractive error globally.

As “Optometry’s Charity,” OGS raises funds from optometrists, optometry practices, and optometry-related businesses and corporations to award annual grants for sustainable, impactful projects that expand the profession and improve access to vision care in underserved areas of the world. Since the grant program began, OGS has awarded more than 200 grants totaling more than $23 million.

This year’s grantee organizations and projects funded are:

  • African Eye Institute Trust

This project by the African Eye Institute Trust includesprovidingeye exams and free eyeglasses for children; vision screening training for teachers and others; and working with the government to prioritize child eye health in South Africa.

  • Berkeley Vision

The grant will fund the screening of 20,000 children at schools in underserved areas of Karachi, Pakistan by providing free refraction services and eyeglasses; and referring children needing advanced eye examinations to hospitals. Also included is training for optometrists, project staff, and school teachers.

  • Brien Holden Vision Institute Foundation Project
    The grant will fund the ongoing expansion and enhancement of clinical care at the Pediatric Refractive Error Training Centre in Hanoi, Vietnam. The Centre, established in part by previous grants from OGS, is the clinical training and patient care facility affiliated with Hanoi Medical University’s Optometry Program.               
  • Canadian Vision Care

Canadian Vision Care will use this grant to repair and maintain the vision teaching center facility for the University of Mzuzu’s Optometry Program in Mzuzu, Malawi. The university program, funded in part by Optometry Giving Sight in 2008, has resulted in the graduation of more than 60 optometrists to date.

  • Healing California

    Healing California will use this grant to provide pop-up and mobile vision clinics throughout California for people in need of vision care.
  • India Vision Institute

This grant will be used by the India Vision Institute to provide training in teaching and instruction to 100 optometry faculty members at 40 optometry schools in India. It is estimated that the additional training will enable faculty members to positively impact the education of 3,200 optometry students throughout the country.

  • Light for the World International

Light for the World International will use this grant to train 20 optometrists employed by the national Mozambique government. Participants will undergo specialized training in critical skills related to pediatric eye care, including pediatric refraction and optical corrections.

  • See Better. Learn Better Jamaica, LTD

The organization will use this grant to provide optometry services and improve the eye health system in western Jamaica. Included in the project are: eye exams and eyeglasses for school-aged children; training of optometry students and opticians and; collaborative efforts with local hospitals and other eye care providers on the island.

  • Special Olympics International

This grant will fund initiatives to improve the vision and health of people with intellectual disabilities and raise awareness of vision care’s role in their well-being.  Funding will be used in support of the organization’s Opening Eyes program, which provides free eye exams and eye glasses to Special Olympics athletes. A portion of the award will also be used to provide specialized training for optometrists, optometry students, and other eye care practitioners who volunteer to provide the exams.

  • Technological University of Santiago (UTESA)

The grant will enable UTESA to provide comprehensive eye exams and eyeglasses to 1,000 public school children in Santo Domingo, Dominican Republic. A portion of the funding will also be used to gather research data on the prevalence of refractive error and visual impairment within the Dominican population. Results will be presented to local Dominican authorities, at the American Academy of Ophthalmology Congress, and published in a peer-reviewed journal.

  • Université de Montréal (UdeM)/Unité de Santé Internationale (USVI)
    The project funded by this grant will support the development of new or emerging optometry programs in La Francophonie, namely in Morocco, Republic of Congo, Lebanon, Vietnam, Mali and Senegal.
  • Université de Montréal

This grant will fund the continuing development and growth of the School of Optometry at the University of Haiti in Port-Au-Prince. The school was established in 2017 in part by funding from Optometry Giving Sight and recognized its first cohort of Haitian optometrists this year.

  • Vision Action

Vision Action will use this grant to strengthen the optometry profession in Sierra Leone, which currently includes only eight optometrists and 17 optometry technicians. Funding will be used train additional optometry technicians and to support the upcoming launch of the Optometry Association in Sierra Leone to make available continuing professional development for current and future optometrists in the country.

  • Volunteer Optometric Services to Humanity California (VOSH California)

This grant will be used by VOSH California to develop an optical lab at the National Autonomous University of Nicaragua (UNAN). In collaboration with other organizations, Optometry Giving Sight helped fund the creation of a School of Optometry at the university.  The award will allow for the purchase of a patternless edger and 20,000 single vision lenses so that many of the eyeglasses prescribed via the school’s community outreach programs can be created on-site, at a much lower cost, allowing for more subsidized or free glasses to those who cannot afford them.

  • Volunteer Optometric Services to Humanity (VOSH International, Inc.)
    This grant will be used toprovide training and equipment for faculty and students of optometry schools in low and middle-income settings within Latin America, Africa and the Middle East. Funds will also enable VOSH to offer primary vision care services and eyeglasses to patients in the regions. 
  • World Council of Optometry

The World Council of Optometry will use this grant to offer its Optometry Program in Advocacy and Leadership (OPAL) training to practitioners from countries in which the profession is not yet fully established. The ongoing program is offered virtually and provides participants from throughout the world with the tools and resources they need to develop sustainable vision care advocacy programs in their countries.

During the last 21 years, OGS has funded the establishment of 14 optometry schools in areas of need, trained more than 14,000 optometrists and eye care personnel worldwide, established more than 130 vision centers for clinical training and patient care and served more than 8 million individuals in 47 countries.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

Fighting Blindness Canada research

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet age-related macular degeneration (wet AMD). The Johns Hopkins University study followed 42 patients for 2 years after gene therapy treatment.

Injected RGX-314 gene therapy produces an anti-VEGF drug called ranibizumab (Lucentis), which is a commonly used therapy for wet AMD. Retinal injection allows cells to make their own anti-VEGF medicine and hopefully reduces or eliminates the need for regular injections. In this study, there was a 60-80% reduction in the number of injections that patients needed. After injection of the gene therapy, patients received 1-4 injections per year compared to about 10 injections before gene therapy.

The treatment is now being tested in two larger Phase 3 clinical trials to ensure that it is safe and effective.

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CooperVision
CooperVision Canadian visit in Costa Rica

CooperVision recently hosted an Innovation Tour for 20 eye care professionals from across Canada at its state-of-the-art, LEED® certified manufacturing facility located in San José, Costa Rica. The three-day event was part of the company’s Canadian launch of its new clariti® 1 day multifocal 3 Add contact lenses.

Attendees were provided a behind-the-scenes look into the innovative design and manufacturing of CooperVision’s full family of clariti 1 day contact lenses, heard unique insights into the lives of today’s patients with presbyopia, and learned more about the company’s leadership in sustainability. The group also had the opportunity to participate in the planting of 75 trees in the lush forests of Costa Rica in partnership with Fundecor, a reforestation organization.

“I feel good knowing that when I prescribe clariti 1 day multifocal 3 Add contact lenses, I’m providing my patients with improved vision at all distances and freedom from reading glasses, while also doing my part in making a positive impact on the environment.”

Pamela Schmitz, OD, Whitby Vision Care in Ontario

Beth Lennox, OD, returned to her Ontario practice, Cambridge Eye Care, feeling empowered to educate both her team and her patients about CooperVision contact lenses and sustainability. “It was incredible to see sustainable manufacturing and operations firsthand and learn how CooperVision is finding innovative ways to ‘go green’ for the benefit of not only our patients, but the planet.”

To learn more about CooperVision’s clariti 1 day multifocal 3 Add lenses, please visit https://coopervision.ca/contact-lenses/clariti-1-day-multifocal.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. logos

The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. have announced the signing of a Memorandum of Understanding (MoU) to establish a collaborative partnership focused on developing innovative technologies for dry eye disease and other ocular surface conditions. By leveraging SCOPE’s knowledge and expertise in eye drop product formulation science, together with CEVR’s extensive experience in ocular drug discovery and delivery translational research, the pair are committed to developing innovative product approaches for doctor and patient unmet ocular surface disease needs.

Professor Ben Thompson, CEO and scientific director of CEVR, remarked, “We are thrilled to collaborate with SCOPE Health Inc., a leading innovator in management solutions for ocular surface diseases. Through this collaboration and SCOPE’s ardent support, engagement in areas such as dry eye management at the practice level and global outreach will increase substantially to deliver tangible change. The research results will advance CEVR’s mission to develop technologies that preserve and enhance vision worldwide. This partnership merges cutting-edge science with formulation and commercialization expertise, paving the way for a transformative solution to support developing technologies that preserve and enhance healthy vision worldwide.”

“Disrupting the status quo and establishing a new standard of care for ocular surface diseases requires collective efforts. Under the leadership of CEVR’s Principal Investigators, Prof. Lyndon Jones, and Dr. Chau-Minh Phan, along with Dr. Howard Ketelson, head of Ideation & Discovery at SCOPE, this collaboration collectively harnesses our expertise’s to develop and commercialize differentiated and clinically valued eyecare products.”

Tom Freyne, CEO, SCOPE Health Inc.

 
Click HERE for the full press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

SightGlass Vision

Three newly published peer reviewed papers are further expanding the extensive scientific evidence base of SightGlass Vision’s Diffusion Optics Technology(DOT 0.2) use for myopia management with children.

“Independently, these Open Access papers each deepen knowledge of our innovative technology among the global ophthalmology and optometry communities. Collectively, they are providing eye care professionals with even more confidence in our approach and the impact that DOT lenses can have on children’s lives today and in the future.”

Marcella McParland, BSc, MCOptom, FAAO, FIACLE, FBCLA, vice president of Clinical, Medical & Professional Affairs, SightGlass Vision 

SightGlass Vision

“Control of Myopia Using Diffusion Optics Spectacle Lenses: 4-Year Results of a Multicentre Randomised Controlled, Efficacy and Safety Study (CYPRESS)” (Laughton D, et al) appears in BMJ Open Ophthalmology.[1] The study demonstrates that DOT 0.2 spectacle lenses are safe and effective at reducing myopia progression, significantly slowing eye growth, with additional benefit evident in the fourth year of wear.

In addition to supporting the hypothesis that a slight lowering of retinal contrast can slow the progression of myopia, the clinical trial is first multicenter study to demonstrate myopia control in an ethnically diverse population with children as young as age six. This outcome in younger patients is noteworthy, due to their fast physiological and myopic eye growth.

Published in Ophthalmic & Physiological Optics, the journal of The College of Optometrists, “Visual Impact of Diffusion Optic Technology Lenses for Myopia Control” affirms that the SightGlass Vision mechanism provides a clinically equivalent visual experience to standard single vision lenses across key measures.[2] The study at six U.S. sites was led by Professor James S. Wolffsohn, chief scientific officer for the International Myopia Institute and head of the Aston University School of Optometry.

Wolffsohn and his co-authors emphasized that DOT lenses provided a clinically equivalent visual experience to standard single vision lenses and did not compromise reading speed, critical print size, and near visual acuity; maintained normal head posture and contrast sensitivities; and demonstrated excellent high- and low-contrast visual acuities and stereopsis.

Written by noted vision scientists and researchers Drs. Jay Neitz and Maureen Neitz, “Diffusion Optics Technology (DOT): A Myopia Control Spectacle Lens Based on Contrast Theory” presents an in-depth review of the science behind DOT’s innovative methodology.[3] Appearing in Translational Vision Science & Technology, the paper explores the fundamentals of contrast theory, how it compares to blur and defocus approaches, and the resulting implications for the design of optical interventions.

SightGlass Vision image 2 asian girl wearing glasses with her family

SightGlass Vision’s patent-protected technology has made its commercial debut in several markets, including China, the Netherlands, Israel, and Canada, as well as through preliminary market trials in other countries. The company operates as a joint venture of CooperCompanies and EssilorLuxottica. For more information, visit SightGlassVision.com.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!


 References

[1] Laughton D, et al. Control of myopia using diffusion optics spectacle lenses: 4-year results of a multicentre randomised controlled, efficacy and safety study (CYPRESS). BMJ Open Ophthalmology 2024;9:e001790.

[2] Wolffsohn JS, Hill JS, Hunt C, Young G. Visual impact of diffusion optic technology lenses for myopia control. Ophthalmic Physiol Opt. 2024; 44: 1398–1406.

[3] Neitz J, Neitz M. Diffusion Optics Technology (DOT): A Myopia Control Spectacle Lens Based on Contrast Theory. Trans. Vis. Sci. Tech. 2024;13(10):42.

Featured Posts

Silmo Paris nouvelle image de marque 2026

Joachim Froment Named Jury President for SILMO d’Or 2026

SILMO Paris has appointed Brussels-based designer Joachim Froment as president of the jury for the SILMO d’Or 2026.

Learn More
Centennial dili dalli logos 2026

Dilli Dalli Pediatric Eyewear Now Available in Canada Through Centennial Optical

Dilli Dalli pediatric eyewear is now available in Canada through Centennial Optical, bringing one of the best-known U.S. pediatric frame brands to Canadian eye care professionals.

Read more
Optik Voila May-June 2026 AYA Horizon C1 Turquoise

New Horizon: Contemporary Design Meets Indigenous Storytelling

AYA Optical introduces Horizon, a contemporary geometric optical frame crafted from lightweight stainless steel and featuring original commissioned artwork by Ojibwe artist Donald Chrétien.

Read more
Centennial demi and dash logos 2026

Demi + Dash Eyewear Now Available in Canada Through Centennial Optical

Demi + Dash eyewear is now available in Canada through Centennial Optical, offering pediatric frames designed for style-conscious kids and tweens.

Read more
The Vision Council Foundation logo

The Vision Council Foundation, AccuWeather and The Skin Cancer Foundation Partner on National Sunglasses Day 2026

The Vision Council Foundation, AccuWeather and The Skin Cancer Foundation have joined forces on a National Sunglasses Day 2026 campaign promoting daily UV protection for eyes and skin.

Read more
Silmo Paris nouvelle image de marque 2026

Joachim Froment Named Jury President for SILMO d’Or 2026

SILMO Paris has appointed Brussels-based designer Joachim Froment as president of the jury for the SILMO d’Or 2026.

Learn More
Centennial dili dalli logos 2026

Dilli Dalli Pediatric Eyewear Now Available in Canada Through Centennial Optical

Dilli Dalli pediatric eyewear is now available in Canada through Centennial Optical, bringing one of the best-known U.S. pediatric frame brands to Canadian eye care professionals.

Read More
Optik Voila May-June 2026 AYA Horizon C1 Turquoise

New Horizon: Contemporary Design Meets Indigenous Storytelling

AYA Optical introduces Horizon, a contemporary geometric optical frame crafted from lightweight stainless steel and featuring original commissioned artwork by Ojibwe artist Donald Chrétien.

Read More
Centennial demi and dash logos 2026

Demi + Dash Eyewear Now Available in Canada Through Centennial Optical

Demi + Dash eyewear is now available in Canada through Centennial Optical, offering pediatric frames designed for style-conscious kids and tweens.

Read More
The Vision Council Foundation logo

The Vision Council Foundation, AccuWeather and The Skin Cancer Foundation Partner on National Sunglasses Day 2026

The Vision Council Foundation, AccuWeather and The Skin Cancer Foundation have joined forces on a National Sunglasses Day 2026 campaign promoting daily UV protection for eyes and skin.

Read More
Silmo Paris nouvelle image de marque 2026

Joachim Froment Named Jury President for SILMO d’Or 2026

SILMO Paris has appointed Brussels-based designer Joachim Froment as president of the jury for the SILMO d’Or 2026.

Learn More
Centennial dili dalli logos 2026

Dilli Dalli Pediatric Eyewear Now Available in Canada Through Centennial Optical

Dilli Dalli pediatric eyewear is now available in Canada through Centennial Optical, bringing one of the best-known U.S. pediatric frame brands to Canadian eye care professionals.

Read more
Optik Voila May-June 2026 AYA Horizon C1 Turquoise

New Horizon: Contemporary Design Meets Indigenous Storytelling

AYA Optical introduces Horizon, a contemporary geometric optical frame crafted from lightweight stainless steel and featuring original commissioned artwork by Ojibwe artist Donald Chrétien.

Read more
Centennial demi and dash logos 2026

Demi + Dash Eyewear Now Available in Canada Through Centennial Optical

Demi + Dash eyewear is now available in Canada through Centennial Optical, offering pediatric frames designed for style-conscious kids and tweens.

Read more
The Vision Council Foundation logo

The Vision Council Foundation, AccuWeather and The Skin Cancer Foundation Partner on National Sunglasses Day 2026

The Vision Council Foundation, AccuWeather and The Skin Cancer Foundation have joined forces on a National Sunglasses Day 2026 campaign promoting daily UV protection for eyes and skin.

Read more
Silmo Paris nouvelle image de marque 2026

Joachim Froment Named Jury President for SILMO d’Or 2026

SILMO Paris has appointed Brussels-based designer Joachim Froment as president of the jury for the SILMO d’Or 2026.

Learn More
Centennial dili dalli logos 2026

Dilli Dalli Pediatric Eyewear Now Available in Canada Through Centennial Optical

Dilli Dalli pediatric eyewear is now available in Canada through Centennial Optical, bringing one of the best-known U.S. pediatric frame brands to Canadian eye care professionals.

Read more
Optik Voila May-June 2026 AYA Horizon C1 Turquoise

New Horizon: Contemporary Design Meets Indigenous Storytelling

AYA Optical introduces Horizon, a contemporary geometric optical frame crafted from lightweight stainless steel and featuring original commissioned artwork by Ojibwe artist Donald Chrétien.

Read more
Centennial demi and dash logos 2026

Demi + Dash Eyewear Now Available in Canada Through Centennial Optical

Demi + Dash eyewear is now available in Canada through Centennial Optical, offering pediatric frames designed for style-conscious kids and tweens.

Read more
The Vision Council Foundation logo

The Vision Council Foundation, AccuWeather and The Skin Cancer Foundation Partner on National Sunglasses Day 2026

The Vision Council Foundation, AccuWeather and The Skin Cancer Foundation have joined forces on a National Sunglasses Day 2026 campaign promoting daily UV protection for eyes and skin.

Read more